Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Non-Standardized Food Allergenic Extract [EPC]
Elm allergenic extracts are biological products used for the diagnosis and treatment of Elm pollen allergies. Belonging to the Non-Standardized Pollen Allergenic Extract class, these extracts are essential for allergen immunotherapy and diagnostic skin testing.
Name
Elm
Raw Name
ELM
Category
Non-Standardized Food Allergenic Extract [EPC]
Drug Count
7
Variant Count
7
Last Verified
February 17, 2026
About Elm
Elm allergenic extracts are biological products used for the diagnosis and treatment of Elm pollen allergies. Belonging to the Non-Standardized Pollen Allergenic Extract class, these extracts are essential for allergen immunotherapy and diagnostic skin testing.
Detailed information about Elm
References used for this content
This page is for informational purposes only and does not replace medical advice. Consult a qualified healthcare professional before using any medication containing Elm.
Elm (Ulmus species) allergenic extracts are sterile biological solutions derived from the pollen of various trees within the Ulmaceae family, most notably the American Elm (Ulmus americana), Cedar Elm (Ulmus crassifolia), and Chinese Elm (Ulmus parvifolia). In the landscape of clinical immunology, Elm extracts are classified as Non-Standardized Pollen Allergenic Extracts [EPC]. These products are regulated by the FDA's Center for Biologics Evaluation and Research (CBER) and are primarily utilized in the practice of allergy and immunology for two distinct purposes: the diagnostic identification of Type I hypersensitivity (allergic) reactions and the therapeutic administration of Allergen Immunotherapy (AIT), commonly referred to as 'allergy shots.'
Historically, Elm tree pollen has been recognized as a significant seasonal aeroallergen, particularly in temperate regions of North America and Europe. The extracts are prepared by extracting the allergenic proteins from the raw pollen using aqueous or glycerinated buffers. Because these extracts are 'non-standardized,' their potency is typically expressed in terms of weight/volume (w/v) ratios (e.g., 1:10, 1:20) or Protein Nitrogen Units (PNU) per milliliter, rather than Bioequivalent Allergen Units (BAU). This lack of standardization requires healthcare providers to exercise extreme caution when switching between different manufacturers or lots, as the biological activity can vary significantly.
While the primary classification involves pollen extracts, Elm-derived substances sometimes appear in broader regulatory categories including Non-Standardized Food Allergenic Extract [EPC] and Non-Standardized Plant Allergenic Extract [EPC], reflecting the botanical complexity of the genus. Interestingly, some regulatory databases link these botanical entries with broader EPC tags like Vitamin D [EPC] or Adrenocorticotropic Hormone [EPC], though in a clinical setting, Elm extracts are strictly utilized for their immunological properties rather than hormonal or vitamin supplementation.
At the molecular level, Elm allergenic extracts work by interacting with the patient's immune system to first identify and then modulate the allergic response.
When used for skin testing (prick-puncture or intradermal), the Elm extract introduces specific allergens (proteins) into the skin. In a sensitized individual, these proteins cross-link allergen-specific Immunoglobulin E (IgE) antibodies bound to the surface of mast cells and basophils. This cross-linking triggers degranulation, releasing inflammatory mediators such as histamine, leukotrienes, and prostaglandins. This results in the classic 'wheal and flare' reaction—a localized area of swelling and redness—which confirms the patient's sensitivity to Elm pollen.
The therapeutic goal of Elm extract administration is the induction of immunological tolerance. When administered subcutaneously in gradually increasing doses (the 'build-up' phase), the extract induces a shift in the immune system's profile. Key changes include:
Unlike traditional small-molecule drugs, the pharmacokinetics of Elm allergenic extracts are not characterized by traditional absorption, distribution, metabolism, and excretion (ADME) studies. As a biological product consisting of complex proteins, its 'disposition' is localized to the immune system.
Elm allergenic extracts are FDA-approved for the following indications:
Elm extracts are available in several specialized forms for clinical use:
> Important: Only your healthcare provider can determine if Elm is right for your specific condition. The administration of these extracts must always be performed in a clinical setting equipped to handle severe allergic reactions.
Dosage for Elm allergenic extracts is highly individualized and must be determined by an allergist or immunologist based on the patient's sensitivity levels. There is no 'standard' dose for non-standardized extracts.
Elm allergenic extracts are generally considered safe for use in children, though the decision to start immunotherapy in very young children (under age 5) must be carefully weighed against the difficulty of the child communicating early symptoms of a systemic reaction. The dosing schedule for children is typically the same as for adults, though the starting dose may be more conservative based on the child's weight and sensitivity profile.
No specific dose adjustments are required for patients with renal impairment, as the extracts are not cleared via the kidneys. However, the patient's overall health and ability to tolerate a potential systemic reaction must be considered.
No adjustments are necessary for hepatic impairment. The metabolic processing of allergenic proteins occurs locally and via the lymphatic system.
Caution is advised in elderly patients, particularly those with underlying cardiovascular disease. If a systemic reaction occurs, the use of epinephrine may pose a higher risk in this population. Dosages should be titrated carefully.
Elm allergenic extracts are never for self-administration. They must be administered by a healthcare professional.
If a dose is missed during the build-up phase, the next dose may need to be reduced or the previous dose repeated, depending on how much time has elapsed. If a maintenance dose is missed by more than a week, the physician may reduce the dose to ensure safety upon resumption. Do not 'double up' on doses to catch up.
An overdose of Elm extract (either too high a volume or too high a concentration) can lead to severe systemic reactions or anaphylaxis.
> Important: Follow your healthcare provider's dosing instructions exactly. Do not adjust your dose or frequency without medical guidance from your allergist.
Most patients receiving Elm allergenic extracts will experience some form of local reaction at the site of injection. These are generally considered a normal part of the body's response to the allergen.
> Warning: Stop taking Elm and call your doctor or emergency services immediately if you experience any of the following symptoms of a systemic reaction or anaphylaxis.
There are no known long-term 'toxic' effects of Elm allergenic extracts. Because they are biological proteins, they do not accumulate in the body like certain chemicals. However, the primary long-term risk is the development of new sensitivities or the rare occurrence of an autoimmune-like response, though this remains largely theoretical in the context of standard immunotherapy.
Allergenic extracts, including Elm, carry a prominent warning regarding the risk of Anaphylaxis.
Report any unusual symptoms or reactions to your healthcare provider before your next scheduled injection. Keeping a 'reaction diary' can be helpful for your allergist to track your progress and safety.
Elm allergenic extracts are potent biological agents that must be handled with extreme care. The most critical safety consideration is the prevention and management of anaphylaxis. Patients must be in a stable state of health before receiving an injection; for example, if a patient is currently experiencing an acute asthma flare or a fever, the injection should typically be postponed.
No FDA black box warnings for Elm are listed in the same format as small-molecule drugs (like antidepressants), but the Standardized Warning Label for Allergenic Extracts is equivalent in gravity. It states that these products are intended for use only by physicians experienced in administering allergenic extracts and that they can cause severe systemic reactions, including death. It specifically highlights that the risk is increased in patients with highly sensitive skin or those receiving high doses.
Most patients can drive after the 30-minute observation period. However, if a patient experiences a systemic reaction, feels dizzy, or takes an antihistamine that causes drowsiness, they should avoid driving or operating heavy machinery.
While there is no direct chemical interaction between alcohol and Elm extract, alcohol consumption can cause vasodilation (widening of blood vessels), which may theoretically increase the speed of allergen absorption or worsen the symptoms of an allergic reaction. It is generally advised to avoid alcohol for several hours before and after an injection.
Immunotherapy is typically a long-term commitment (3 to 5 years). Stopping Elm injections abruptly does not cause 'withdrawal' in the traditional sense, but the patient's allergy symptoms will likely return over time. If the treatment is stopped for an extended period and then restarted, the physician must restart at a much lower dose to avoid a reaction.
> Important: Discuss all your medical conditions, especially heart or lung problems, with your healthcare provider before starting Elm immunotherapy.
There are few absolute contraindications for drug combinations, but the following are considered highly dangerous:
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking, especially any medications for blood pressure or heart rhythm.
Elm allergenic extracts must NEVER be used in the following circumstances:
Conditions requiring a careful risk-benefit analysis include:
Patients allergic to Elm may also show sensitivity to other members of the Ulmaceae family. Additionally, there is some documented cross-reactivity between Elm pollen and certain other tree pollens (like Oak or Birch) due to shared protein structures (profilins). If a patient is known to be extremely sensitive to one, the physician should use extra caution when testing or treating with the other.
> Important: Your healthcare provider will evaluate your complete medical history, including your heart and lung health, before prescribing Elm extracts.
Pregnancy Category: Not formally assigned (formerly Category C).
Elm allergenic extracts are complex proteins that are processed locally. It is highly unlikely that any significant amount of the allergen would reach the breast milk or be absorbed by the nursing infant's gut. Breastfeeding is generally considered safe for mothers receiving Elm immunotherapy.
No dosage adjustments are required. The proteins in the extract are not cleared by the kidneys, and there is no evidence of nephrotoxicity.
No dosage adjustments are required. The liver is not involved in the primary metabolism or clearance of subcutaneous allergenic extracts.
> Important: Special populations, particularly pregnant women and the elderly, require a highly individualized medical assessment before undergoing Elm immunotherapy.
Elm allergenic extracts act as biological response modifiers. In the diagnostic phase, they trigger a localized Type I hypersensitivity reaction mediated by IgE. In the therapeutic phase (AIT), they induce 'desensitization' and long-term 'tolerance.'
| Parameter | Value |
|---|---|
| Bioavailability | N/A (Subcutaneous administration) |
| Protein Binding | N/A (Processed by immune cells) |
| Half-life | Variable (Proteins degraded within hours/days) |
| Tmax | 1–2 hours (for systemic absorption of proteins) |
| Metabolism | Proteolysis by antigen-presenting cells |
| Excretion | Not renally excreted |
Elm belongs to the Non-Standardized Pollen Allergenic Extract [EPC] class. It is grouped with other tree pollens like Oak, Maple, and Birch. It is distinct from 'standardized' extracts like Grass or Dust Mite, which have federally mandated potency tests.
Medications containing this ingredient
Common questions about Elm
Elm allergenic extract is primarily used for the diagnosis and treatment of seasonal allergies caused by Elm tree pollen. In a diagnostic setting, it is used in skin prick tests to confirm if a patient is allergic to Elm. In a therapeutic setting, it is used in allergen immunotherapy (allergy shots) to help the body build up a tolerance to the pollen. This treatment is intended for patients with allergic rhinitis, conjunctivitis, or allergic asthma. It is not used to treat acute symptoms but rather to provide long-term relief.
The most common side effects are local reactions at the site of the injection, occurring in nearly all patients at some point. These include redness, itching, and a raised bump or swelling (wheal) that usually disappears within a few hours. Some patients may also experience mild fatigue or a temporary increase in their typical allergy symptoms, such as sneezing or nasal congestion. These reactions are generally mild and do not require stopping the treatment. However, any large swelling (bigger than a silver dollar) should be reported to your doctor.
There is no direct drug interaction between alcohol and Elm pollen extract, but caution is highly recommended. Alcohol can cause blood vessels to dilate, which might increase the speed at which the allergen is absorbed into your bloodstream, potentially increasing the risk of a systemic reaction. Furthermore, alcohol can mask the early symptoms of anaphylaxis or make them harder to manage. Most allergists suggest avoiding alcohol for at least several hours before and after your allergy shot. Always follow the specific lifestyle advice provided by your immunology clinic.
Elm immunotherapy is generally not started during pregnancy because of the risk of a severe allergic reaction, which could harm the fetus by reducing oxygen supply. However, if a woman is already on a stable maintenance dose and becomes pregnant, many doctors will continue the treatment at that same dose. The extract itself does not cause birth defects, but the management of a potential reaction is the primary concern. You must inform your allergist immediately if you become pregnant or are planning to become pregnant. A careful risk-benefit analysis will be performed for your specific case.
Allergen immunotherapy with Elm extract is a slow process and does not provide immediate relief like an antihistamine. Most patients begin to notice a reduction in their allergy symptoms after reaching the 'maintenance phase,' which typically takes 3 to 6 months of weekly injections. Significant improvement is usually seen after the first full year of treatment. For the best long-term results, the treatment is generally continued for 3 to 5 years. If no improvement is seen after 12–18 months, your doctor may re-evaluate the treatment plan.
Yes, you can stop Elm immunotherapy suddenly without experiencing physical withdrawal symptoms, as it is not an addictive medication. However, stopping the treatment before the recommended 3–5 year course is finished will likely result in the return of your allergy symptoms over time. If you stop for several weeks and then decide to restart, you cannot simply take your last dose; your doctor will need to significantly reduce the dose to ensure your safety. Always discuss your reasons for wanting to stop with your allergist first.
If you miss a scheduled Elm injection, contact your allergy clinic as soon as possible to reschedule. Do not attempt to take an extra dose later to make up for it. The safety of immunotherapy depends on a consistent schedule; if too much time passes between shots, your sensitivity to the allergen may increase. Your doctor may need to repeat your last dose or even reduce the dose slightly for your next visit depending on how many days or weeks have been missed. Consistency is key to both the safety and effectiveness of the treatment.
There is no scientific evidence or clinical data suggesting that Elm allergenic extracts cause weight gain. Unlike oral corticosteroids (like prednisone), which are known to affect metabolism and appetite, allergenic extracts are proteins that work specifically on the immune system. Any changes in weight during treatment are likely due to other factors, such as lifestyle changes, other medications, or unrelated medical conditions. If you experience unexpected weight gain, you should discuss it with your primary care physician to identify the underlying cause.
Elm extracts can be taken alongside most common medications, but there are critical exceptions. You must inform your doctor if you are taking beta-blockers (often prescribed for high blood pressure, heart rhythm, or migraines), as these can make life-saving epinephrine ineffective during an emergency. ACE inhibitors and MAO inhibitors also require caution. While you can take antihistamines, they should be avoided before skin testing because they can block the test results. Always provide your allergist with a complete and updated list of all your current medications.
The concept of 'generic' vs. 'brand name' is slightly different for biological products like Elm extract. While there are multiple manufacturers (such as Greer, HollisterStier, and ALK-Abelló) that produce Elm pollen extracts, these are not considered interchangeable in the same way generic pills are. Each manufacturer's extract may have slightly different protein concentrations and biological activity. Therefore, if your clinic switches manufacturers, your doctor will usually 'back up' or reduce your dose slightly to ensure you can safely tolerate the new product.